Retlirafusp Alfa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Retlirafusp Alfa, covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Retlirafusp Alfa Injection Combined Chemotherapy for Perioperative Treatment of Esophagogastric Junction Adenocarcinoma: A Single-Arm, Phase II Study of Safety and Efficacy [NA]